LoginSignup
Fagron logo

Fagron

Stock
Stock
ISIN: BE0003874915
Ticker: FAGR
BE0003874915
FAGR

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Fagron has so far distributed $0.396 in 2025. 

$0.406

CHART BY

Frequently asked questions

What is Fagron's market capitalization?

The market capitalization of Fagron is $1.74B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Fagron's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Fagron is 17.15. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Fagron?

Fagron's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.38. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Fagron's stock?

Currently, 6 analysts cover Fagron's stock, with a consensus target price of $29.55. Analyst ratings provide insights into the stock's expected performance.

What is Fagron's revenue over the trailing twelve months?

Over the trailing twelve months, Fagron reported a revenue of $1.08B.

What is the EBITDA for Fagron?

Fagron's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $213.78M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Fagron?

Fagron has a free cash flow of $77.02M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Fagron have, and what sector and industry does it belong to?

Fagron employs approximately 3,848 people. It operates in the Health Care sector, specifically within the Medical Distributors industry.

What is the free float of Fagron's shares?

The free float of Fagron is 69.52M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$1.74B
EPS (TTM) 
$1.38
Free Float 
69.52M
P/E ratio (TTM) 
17.15
Revenue (TTM) 
$1.08B
EBITDA (TTM) 
$213.78M
Free Cashflow (TTM) 
$77.02M

Pricing

1D span
$23.20$23.72
52W span
$15.75$26.90

Analyst Ratings

The price target is $29.55 and the stock is covered by 6 analysts.

Buy

6

Hold

0

Sell

0

Information

Fagron NV engages in the development, marketing, and distribution of healthcare products and services. It operates through the following segments: Essentials, Brands, and Compounding Services. The Essential segment focuses on supplying raw materials to community and hospital pharmacies for pharmaceutical compounding. The Brands segment is involved in developing and producing semi-finished products and vehicles, such as emulsions, powder mixtures, creams, and other excipients, as well as total concepts and equipment for pharmaceutical compounding. The Compounding Services segment offers community and hospital pharmacies with ready-to-use non-sterile compounded medicine in those countries where it is permitted. The company was founded in 1990 and is headquartered in Nazareth, Belgium.

Employees
3,848
Industries
Medical Distributors
Sector
Health Care

Identifier

ISIN
BE0003874915
Primary Ticker
FAGR

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin